DOCSLIB.ORG

Cardinal Health Microbiology Catalog

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cardinal Health Microbiology Catalog Laboratory Products Microbiology Laboratory products for your Microbiology needs. Better solutions for your laboratory. Examining the form and structure of microorganisms requires advanced tools. From culture and media supplies to parasitology tests, rely on a complete offering of microbiology products from Cardinal Health to meet your laboratory’s needs. In addition to our microbiology offering, the Cardinal Health laboratory product portfolio features items designed for all disciplines, from hematology to histology. Thousands of supplies from hundreds of leading manufacturers. And our dedicated sales professionals can recommend the best products at the best prices for your lab’s unique needs. Saving you valuable time. Count on Cardinal Health to help you navigate challenges and discover solutions. Allowing you to focus on keeping your lab running smoothly. To hear more about how we can support your lab, contact your Cardinal Health sales representative or call 800.964.5227. Table of Contents Microbiology Analyzers Microbiology Supplies, continued Blood Culture Systems and Accessories . 2-3 Inoculation ID and Susceptibility Systems and Accessories . 4 Loops and Needles . 70-72 Sterilizers . 72 Microbiology Equipment Microorganism Storage . 73 Colony Counters . 5 Tissue Grinders . 74 Incubators . 5-18 Parasitology Safety Cabinets . 18-21 Safety Cabinet Accessories . 22 Collection and Transport . 75 Concentrator Kits . 76 Stainers . 23 Cryptosporidium/Giardia . 77 Microbiology ID and Susceptibility Testing E . Histolyitica . 77 Differentiation/Diagnostic Disks . 24-25 Rapids Diagnostic Disk Dispensers . 26 BD Affirm System and Accessories . 78 General Stains and Supplies . 26-28 Adenovirus . 79 Identification Reagents and Kits . 29-30 Bordetella . 79 Latex Agglutination C . difficile . 79-81 Miscellaneous . 31-36 Campylobacter . 81 Staph . 36-37 Chlamydia . 81 Strep . 38-39 Coccidiodes . 82 Rapid ID Panels . 40 Cryptococcal . 82 Susceptibility/Sensitivity Disks . 41-43 Fecal Occult Blood . 82-84 Typing Sera . 44-45 Flu . 85-86 Microbiology Media H . pylori . 87 Anaerobic Media . 46 HCV . 88 Chromogenic Media . 47 HIV . 88 Prepared Culture Media . 48-49 HSV . 88 Miscellaneous Media Products . 50 Legionella . 88 Manual Blood Culture Systems and Accessories . 51 Lyme . 88 Dehydrated Media . 51-52 MONO . 89 Animal Blood . 52 Mycoplasma . 90 Pneumonia . 90 Microbiology Quality Control Rotovirus . 90 QC Organisms . 53-54 RSV . 90-92 QC Slides . 54-55 EHEC/Shiga Toxin E . coli . 92 Microbiology Supplies Sofia kits . 93 Anaerobic Chambers and Supplies . 56-59 Staph . 93 Collection Systems and Swabs . 60-61 Strep A . 94-98 Transport Systems Syphilis . 98 Anaerobic . 62 Trichomonas . 98 Bacterial . 62-64 VZV . 98 Fecal . 65 Product Index . 99 -112 Flocked Swabs . 66 Catalog Number Index . 113-119 Viral . 67-69 Terms and Conditions of Sale . 120 To order, call: 800.964.5227 cardinalhealth.com 1 Microbiology Analyzers Blood Culture Systems and Accessories Microbiology Analyzers BD BACTEC™ Blood Culture Media BD BACTEC™ FX40 BD DIAGNOSTICS - Designed for maximum safety in sample collection, BD DIAGNOSTICS - The BD BACTEC FX40 blood culture instrument is a the BD BACTEC™ blood culture media allow collection using any modular system that offers lower volume customers the opportunity to standard blood transfer device . Choose from a wide range of access the state-of-the-art workflow and performance of the BD BACTEC BD BACTEC™ blood culture media—from plus and peds media to FX system . fungal and lytic media . • 40 vial capacity in total BD BACTEC™ PEDS Plus® medium has been specifically designed to • Immediate incubation of blood cultures optimize recovery of bacteria and fungi from pediatric and other blood specimens that are generally less than 3 mL in volume . Cat. No. Mfr. No. Description Qty. 442296 442296 BACTEC™ FX40 1/ea BD BACTEC™ Myco/F lytic medium is a nonselective medium designed to enhance recovery of yeast, fungi and mycobacteria from blood and sterile body fluids . Cat. No. Mfr. No. Description Qty. BD BACTEC™ FX 4402192A 442192 Plus aerobic/F medium 50/sp BD DIAGNOSTICS - Blood culture 442023 442023 Plus aerobic/F medium in plastic 50/sp testing is one of the most important 4402193A 442193 Plus anaerobic/F medium 50/sp functions of the microbiology BD442022 442022 Plus anaerobic/F medium in plastic 50/sp laboratory as clinicians rely on this 4402265A 442265 Lytic/10 anaerobic/F medium 50/sp information to aid in the diagnosis of bacteremia and fungemia . The BACTEC 442021 442021 Lytic/10 anaerobic/F medium in plastic 50/sp FX System builds on the proven history 4402194A 442194 PEDS Plus®/F medium 50/sp of previous BACTEC instrumentation; BD442020 442020 PEDS Plus®/F medium in plastic 50/sp it goes much further with exciting 4402191A 442191 Standard anaerobic /F medium 50/sp innovations such as: Vial-activated 4402260A 442260 Standard/10 aerobic /F medium 50/sp workflow, advanced ergonomics, 442003A 442003 Myco/F lytic medium 25/sp remote alarms and blood culture 4402288 442288 Myco/F lytic medium 50/sp observation, and customer-focused 442000A 442000 Blood culture procedural tray 1, adult 20/sp data management . The instrument 442001 442001 Blood culture procedural tray 2, adult 20/sp design provides optimal, easy-to-use 442002A 442002 Blood culture procedural tray 3, peds 20/sp workflow in a compact, modular design . The BACTEC FX System can be adapted for multiple configurations that are space saving and conserve BD BACTEC™ Bottle Holders and Aerobic Vents time for the laboratory staff . BD DIAGNOSTICS - Accessories for the BD BACTEC™ blood culture system include bottle holders for the transport of a single BD BACTEC™ glass vial, as well as aerobic vents for subculturing positive blood cultures to plated media . Cat. No. Mfr. No. Description Qty. 4457A1A 445771 Bottle holder 100/cs Cat. No. Mfr. No. Description Qty. 4349560A 249560 Aerobic vents 50/sp B5063-3 441385 BACTEC™ FX - top unit 1/ea B5063-4 441386 BACTEC™ FX - bottom unit 1/ea 2 Cardinal Health Microbiology Products cardinalhealth.com To order, call: 800.964.5227 To order, call: 800.964.5227 cardinalhealth.com Microbiology Analyzers Blood Culture Systems and Accessories Remel™ Airway Venting and Subculture Needle Unit Thermo Scientific™ VersaTREK™ REDOX™ 2 EZ Draw™ Microbiology Analyzers THERMO FISHER SCIENTIFIC - This sterile needle unit is designed Media (NM-Anaerobic Manual) for subculturing blood culture bottles and venting aerobic blood THERMO FISHER SCIENTIFIC - Perform safe, simple culture bottles . and convenient phlebotomy, without the need for costly blood adapters, with Thermo Scientific™ Cat. No. Mfr. No. Description Qty. VersaTREK™ REDOX™ EZ Draw™ Media, the only R223766 R223766 Sterile airway needles 100/pk FDA-cleared true, direct measured draw in the industry . Accommodating up to 5 mL of blood, EZ Draw media is available in a 40 mL broth for both REDOX 1 aerobic and REDOX 2 anaerobic Thermo Scientific™ VersaTREK™ Myco Media bottles and can be used for manual or automated THERMO FISHER SCIENTIFIC - Reliably detect a wide monitoring of direct-draw blood samples . Plus, variety of mycobacteria species from all specimen the highly-enriched REDOX media supports a wide types with just one bottle using Thermo Scientific™ range of organisms, enhancing the fully automated VersaTREK™ Myco Media . VersaTREK Myco Media VersaTREK System’s ability to better recover fastidious organisms . utilizes a unique growth matrix, via cellulose sponges, to provide better recovery of mycobacteria species Cat. No. Mfr. No. Description Qty. while the VersaTREK instrument’s detection technology Y711044 Y711044 40 mL anaerobic manual media 50/cs automatically incubates and continuously monitors inoculated bottles for reliable, automated myco testing . Cat. No. Mfr. No. Description Qty. Y711142 Y711142 VersaTREK Myco Media 50/cs Thermo Scientific™ VersaTREK™ REDOX™ Media THERMO FISHER SCIENTIFIC - Recover organisms from all patient scenarios and reduce inventory and costs, with Thermo Scientific™ VersaTREK™ REDOX™ Media . REDOX 1 aerobic media and REDOX 2 anaerobic media use dilution and timing to detect microbes and are the only media FDA-cleared for draws as low as 0 .1 mL, perfect for pediatric patients . Plus, the highly-enriched REDOX media supports a wide range of organisms, enhancing the VersaTREK System’s ability to better recover fastidious organisms . Cat. No. Mfr. No. Description Qty. Y710644 Y710644 40 mL aerobic media 50/cs Y710744 Y710744 40 mL anaerobic media 50/cs Y710244 Y710244 80 mL aerobic media 50/cs Y710344 Y710344 80 mL anaerobic media 50/cs Thermo Scientific™ VersaTREK™ Myco PVNA (Polymyxin B, Vancomycin, Nalidixic Acid, Amphotericin B) THERMO FISHER SCIENTIFIC - Accurately detect mycobacteria in potentially contaminated specimens using Thermo Scientific™ VersaTREK™ Myco PVNA (Polymyxin B, Vancomycin, Nalidixic Acid, Amphotericin B . Cat. No. Mfr. No. Description Qty. Y711342 Y711342 25 mL myco antibiotic supplement 5/cs cardinalhealth.com To order, call: 800.964.5227 To order, call: 800.964.5227 cardinalhealth.com 3 Microbiology Analyzers Identification and Susceptibility Systems and Accessories Microbiology Analyzers BD BBL™ Crystal™ Identification Systems BD DIAGNOSTICS - These easy-to-use miniaturized identification systems only require one-step inoculation and provide identification for more than 500 organisms . The systems are closed, once inoculated, providing safety and eliminating the need for reagent addition or oil overlay . MIND software,
Load more

Recommended publications
  • Correlation of Phenotypic Tests with the Presence of the Blaz
    b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 8 (2 0 1 7) 159–166 ht tp://www.bjmicrobiol.com.br/ Medical Microbiology Correlation of phenotypic tests with the presence of the blaZ gene for detection of beta-lactamase a,b a a Adriano Martison Ferreira , Katheryne Benini Martins , Vanessa Rocha da Silva , c a,b,∗ Alessandro Lia Mondelli , Maria de Lourdes Ribeiro de Souza da Cunha a Universidade Estadual Paulista (UNESP), Botucatu Biosciences Institute, Department of Microbiology and Immunology, Botucatu, SP, Brazil b Universidade Estadual Paulista (UNESP), Botucatu School of Medicine University Hospital, Department of Tropical Diseases, Botucatu, SP, Brazil c Universidade Estadual Paulista (UNESP), Botucatu School of Medicine University Hospital, Department of Internal Medicine, Botucatu, SP, Brazil a r a t i c l e i n f o b s t r a c t Article history: Staphylococcus aureus and Staphylococcus saprophyticus are the most common and most impor- Received 3 July 2015 tant staphylococcal species associated with urinary tract infections. The objective of the Accepted 20 June 2016 present study was to compare and to evaluate the accuracy of four phenotypic methods Available online 11 November 2016 for the detection of beta-lactamase production in Staphylococcus spp. Seventy-three strains Associate Editor: John Anthony produced a halo with a diameter ≤28 mm (penicillin resistant) and all of them were positive McCulloch for the blaZ gene. Among the 28 susceptible strain (halo ≥29 mm), 23 carried the blaZ gene and five did not.
    [Show full text]
  • Moraxella Catarrhalis Uses a Twin-Arginine Translocation System to Secrete the Β-Lactamase BRO-2 Rachel Balder1, Teresa L Shaffer2 and Eric R Lafontaine1*
    Balder et al. BMC Microbiology 2013, 13:140 http://www.biomedcentral.com/1471-2180/13/140 RESEARCH ARTICLE Open Access Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2 Rachel Balder1, Teresa L Shaffer2 and Eric R Lafontaine1* Abstract Background: Moraxella catarrhalis is a human-specific gram-negative bacterium readily isolated from the respiratory tract of healthy individuals. The organism also causes significant health problems, including 15-20% of otitis media cases in children and ~10% of respiratory infections in adults with chronic obstructive pulmonary disease. The lack of an efficacious vaccine, the rapid emergence of antibiotic resistance in clinical isolates, and high carriage rates reported in children are cause for concern. Virtually all Moraxella catarrhalis isolates are resistant to β-lactam antibiotics, which are generally the first antibiotics prescribed to treat otitis media in children. The enzymes responsible for this resistance, BRO-1 and BRO-2, are lipoproteins and the mechanism by which they are secreted to the periplasm of M. catarrhalis cells has not been described. Results: Comparative genomic analyses identified M. catarrhalis gene products resembling the TatA, TatB, and TatC proteins of the well-characterized Twin Arginine Translocation (TAT) secretory apparatus. Mutations in the M. catarrhalis tatA, tatB and tatC genes revealed that the proteins are necessary for optimal growth and resistance to β-lactams. Site-directed mutagenesis was used to replace highly-conserved twin arginine residues in the predicted signal sequence of M. catarrhalis strain O35E BRO-2, which abolished resistance to the β-lactam antibiotic carbanecillin. Conclusions: Moraxella catarrhalis possesses a TAT secretory apparatus, which plays a key role in growth of the organism and is necessary for secretion of BRO-2 into the periplasm where the enzyme can protect the peptidoglycan cell wall from the antimicrobial activity of β-lactam antibiotics.
    [Show full text]
  • Section 13. Laboratory Considerations
    Section 13. Laboratory Considerations Table of Contents 13.1 Overview and General Guidance 13.2 Specimen Labeling 13.3 Procedures for Specimens That Cannot be Evaluated 13.4 Use of LDMS 13.5 Documentation 13.6 Urine Testing 13.6.1 Specimen Collection 13.6.2 Pregnancy Testing 13.6.3 Chlamydia and Gonorrhea Testing 13.6.4 Urine Culture 13.7 Blood Testing 13.7.1 Specimen Collection and Initial Processing 13.7.2 HIV Testing 13.7.3 Syphilis Testing 13.7.4 Hematology Testing 13.7.5 Serum Chemistries 13.7.6 Plasma Storage 13.7.7 CD4+ T Cell Count 13.7.8 HIV RNA PCR 13.7.9 HIV DNA PCR 13.8 Testing of Vaginal and Cervical Specimens 13.8.1 Vaginal pH 13.8.2 Wet Mount for Candidiasis and BV 13.8.3 Rapid Test for Trichomoniasis 13.8.4 Vaginal Gram Stain 13.8.5 Papanicolaou (Pap) Test 13.8.6 Self-Administered Vaginal Swabs for PK and biomarker testing 13.8.7 Endocervical Swabs for Biomarker Analysis 13.8.8 Intra-Vaginal Ring Storage 13.8.9 Herpes Lesion Testing Table 13-1 Volume Guide for Plasma Storage Appendix 13-1 Overview of Laboratory Testing Locations, Specimens, and Methods for MTN-020 Appendix 13-2 MTN-020 Lab Specimen Processing Guidelines Appendix 13-3 LDMS Specimen Management Guide to Logging in MTN-020 Specimens Appendix 13-4 MTN-020 HIV Testing Algorithms Appendix 13-5 MTN Network Lab HIV Query Form Appendix 13-6 LDMS Tracking Sheets This section contains information on the laboratory procedures performed in MTN-020.
    [Show full text]
  • Use of the Diagnostic Bacteriology Laboratory: a Practical Review for the Clinician
    148 Postgrad Med J 2001;77:148–156 REVIEWS Postgrad Med J: first published as 10.1136/pmj.77.905.148 on 1 March 2001. Downloaded from Use of the diagnostic bacteriology laboratory: a practical review for the clinician W J Steinbach, A K Shetty Lucile Salter Packard Children’s Hospital at EVective utilisation and understanding of the Stanford, Stanford Box 1: Gram stain technique University School of clinical bacteriology laboratory can greatly aid Medicine, 725 Welch in the diagnosis of infectious diseases. Al- (1) Air dry specimen and fix with Road, Palo Alto, though described more than a century ago, the methanol or heat. California, USA 94304, Gram stain remains the most frequently used (2) Add crystal violet stain. USA rapid diagnostic test, and in conjunction with W J Steinbach various biochemical tests is the cornerstone of (3) Rinse with water to wash unbound A K Shetty the clinical laboratory. First described by Dan- dye, add mordant (for example, iodine: 12 potassium iodide). Correspondence to: ish pathologist Christian Gram in 1884 and Dr Steinbach later slightly modified, the Gram stain easily (4) After waiting 30–60 seconds, rinse with [email protected] divides bacteria into two groups, Gram positive water. Submitted 27 March 2000 and Gram negative, on the basis of their cell (5) Add decolorising solvent (ethanol or Accepted 5 June 2000 wall and cell membrane permeability to acetone) to remove unbound dye. Growth on artificial medium Obligate intracellular (6) Counterstain with safranin. Chlamydia Legionella Gram positive bacteria stain blue Coxiella Ehrlichia Rickettsia (retained crystal violet).
    [Show full text]
  • Syphilis Diagnosis: Three Cases with Increasing Treponemal Test Result After Therapy
    Acta Derm Venereol 2014; 94: 323–324 SHORT COMMUNICATION Syphilis Diagnosis: Three Cases with Increasing Treponemal Test Result after Therapy Henrik O. Larsson1*, Annika Johnsson2 and Anders Bredberg1 Departments of 1Medical Microbiology, and 2Dermatology and Venereology, Skane University Hospital, Lund University, Jan Waldenströms gata 59, SE- 205 02 Malmö, Sweden. *E-mail: [email protected] Accepted May 4, 2013 Epub ahead of print Oct 3, 2013 Serology is a main tool for syphilis diagnostic work used (the Captia Syphilis-Enzywell Treponema IgG and IgM, (1–3). According to a recent survey performed by the respectively, EIA from Diesse, Monteriggioni, Italy); the IgG method uses antigen-coated wells and IgM is determined by U.S. Centers for Disease Control and Prevention (CDC) capture technique; a value over 1.0 is considered to be reactive 56% of infectious disease specialists responded that they (7). Particle agglutination was done at serum dilution 80 with send a rapid plasma reagin (RPR) test to the laboratory no quantitation of the result (TPPA, Fujirebio, Tokyo, Japan). and treat presumptively for syphilis (if result is negative 18% repeat the RPR testing before treating the patient, and 17% treat only if RPR is positive) (4). However, a RESULTS clearly positive reaction may be missing at the first visit Case 1 was tested twice, at 6 days before and 112 of patients with active syphilis (5). Non-treponemal test days after treatment start (Fig. 1, upper panel). The (e.g. RPR and Venereal Disease Research Laboratory treponemal screening value is rising from 4 to a highly (VDRL)) reactivity is known to decrease in response to reactive value of 14, while the non-treponemal VDRL therapy, in contrast to the typically life-long persistence titre decreases from a weak 1 to negativity.
    [Show full text]
  • Medical Bacteriology
    LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology.
    [Show full text]
  • Rapid Syphilis Testing Protocol Wisconsin Department of Health Services STD Control Program
    Rapid Syphilis Testing Protocol Wisconsin Department of Health Services STD Control Program P-01832 June 2017 Table of Contents Bureau of Communicable Diseases (BCD) Staff Contact List ........................................................................ 3 Common Acronyms and Terms ..................................................................................................................... 4 Introduction and Background ....................................................................................................................... 5 Syphilis FAQ ................................................................................................................................................... 6 Rapid Syphilis Testing Algorithm ................................................................................................................... 9 Program Requirements ............................................................................................................................... 10 Agency Flow of Services .............................................................................................................................. 15 Rapid Syphilis Testing in Nontraditional or Outreach Settings ................................................................... 15 Syphilis Risk Assessment with Rapid Tests ................................................................................................. 17 Syphilis Health Check Testing Kit ...............................................................................................................
    [Show full text]
  • Evaluation of a Highly Sensitive Method of Measuring Syphilis TP Antibody, and a New Approach to Syphilis Testing
    Sysmex Journal International Vol. 22 No. 1 Evaluation of a Highly Sensitive Method of Measuring Syphilis TP Antibody, and a New Approach to Syphilis Testing Hiroshi SHIBATA, Hidehiko MORIYAMA, Yuki TANIGUCHI, Chikafumi MATSUDA and Atsushi NAGAI Central Clinical Laboratory, Shimane University Hospital 89-1 Enya, Izumo, Shimane, 693-8501 Japan. INTRODUCTION facilitates reaction between the sample (TP-Ab) and a biotinylated TP-Ag. In the next step, there is binding with Syphilis is a typical systemic sexually transmitted disease streptavidin-coated magnetic particles. Then, after that is caused by infection by Treponema pallidum (TP), bound/free (B/F) separation, the complex is further a pathogenic spirochete. Immunoserological tests with bound to ALP-labeled TP-Ag. After another B/F serum samples are generally used for testing TP separation, the chemiluminescent substrate CDP-Star is infection. These are typically TP antibody (TP-Ab) added and the intensity of luminescence measured. assays wherein a TP bacterial component is used as the We used VIRATROL (Sysmex) for examining the antigen, and serological test for syphilis (STS) that uses accuracy of the measurement, and an enzyme linked the phospholipid cardiolipin as the antigen. immunosorbent assay using TPauto·FS (KW) (ELSIA- In recent years, along with the advancement of testing TP; Sysmex) as the control for comparing the test results. methods, syphilis TP-Ab testing has been automated and Samples with disagreement of findings were investigated there have been considerable advances in improving through testing by TP hemagglutination assay (TPHA) sensitivity, speed and labor savings. We shall report here (Fujirebio Inc.), rapid plasma reagin (RPR) carbon the results of basic investigations on TP-Ab antigen test (Dainippon Sumitomo Pharma), and measurements using a recombinant TP antigen (TP-Ag) fluorescent Treponema antibody absorption test (FTA- and the automated immunoassay system HISCL-2000i ABS) (Nihon BCG Supply).
    [Show full text]
  • Β-Lactamase Production and Antibiotic Susceptibility Pattern of Moraxella
    Shi et al. BMC Microbiology (2018) 18:77 https://doi.org/10.1186/s12866-018-1217-5 RESEARCH ARTICLE Open Access β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China Wei Shi1†, Denian Wen2†, Changhui Chen3†, Lin Yuan1, Wei Gao1, Ping Tang2, Xiaoping Cheng3 and Kaihu Yao1* Abstract Background: Moraxella catarrhalis (M. catarrhalis) is an important bacterial pathogen. However, its antibiotic susceptibility patterns in different areas are difficult to compare because of the use of different methods and judgement criteria. This study aimed to determine antimicrobial susceptibility and β-lactamase activity characteristics of M. catarrhalis isolates collected from two county hospitals in China, and to express the results with reference to three commonly used judgement criteria. Results: Nasopharyngeal swabs were obtained from child inpatients with respiratory tract infections at the People’s Hospital of Zhongjiang County and Youyang County from January to December 2015. M. catarrhalis strains were isolated and identified from the swabs, and susceptibility against 11 antimicrobials was determined using the E-test method or disc diffusion. Test results were interpreted with reference to the standards of the European Committee on Antimicrobial Susceptibility Testing (EUCAST), the Clinical and Laboratory Standards Institute (CLSI), and the British Society for Antimicrobial Chemotherapy (BSAC). Detection of β-lactamase activity was determined by the chromogenic cephalosporin nitrocefin. M. catarrhalis yield rates were 7.12 and 9.58% (Zhongjiang County, 77/1082 cases; Youyang County, 101/1054 cases, respectively). All isolates were susceptible to amoxicillin–clavulanic acid. The susceptibility rate to meropenem was 100% according to EUCAST; no breakpoints were listed in CLSI or BSAC.
    [Show full text]
  • ISSN: 2320-5407 Int. J. Adv. Res. 4(11), 182-187 RESEARCH ARTICLE
    ISSN: 2320-5407 Int. J. Adv. Res. 4(11), 182-187 Journal Homepage: -www.journalijar.com Article DOI:10.21474/IJAR01/2069 DOI URL: http://dx.doi.org/10.21474/IJAR01/2069 RESEARCH ARTICLE PHENOTYPIC DETECTION OF B-LACTAMASE PRODUCING STAPHYLOCOCCUS AUREUS CLINICAL ISOLATES. Manal A.A, Omnia M.A*and Hoda E.A. Department of clinical pathology, Faculty of Medicine Ain Shams University, Cairo, Egypt. …………………………………………………………………………………………………….... Manuscript Info Abstract ……………………. ……………………………………………………………… Manuscript History More than 90% of Staphylococcal Aureus isolates produce penicillinase, regardless of the clinical setting. However, penicillin Received: 24 September 2016 remains the treatment of choice for penicillin-susceptible Final Accepted: 25 October 2016 Staphylococcus aureus. A number of phenotypic methods for the Published: November 2016 detection of β-lactamase production in Staphylococcus species have Key words:- been investigated and compared to detection of the blaZ gene by PCR. β-lactamse, S. aureus, penicillin, All phenotypic methods had a sensitivity of less than 72%, so nitrocefin, blaZ gene. phenotypic tests with high sensitivity should be adopted to detect β- lactamse production in S. aureus. This would guide the treatment of cases of serious infections requiring penicillin therapy. The present study aims to identify prevalence of S. aureus resistance to penicillin and to evaluate the nitrocefin reaction in detecting β-lactamse production in S. aureus, compared to detection of blaZ- gene presence by real time PCR in S. aureus isolates. The present study was conducted on one hundred clinical isolates of S. aureus that were collected from various clinical specimens. Antimicrobial susceptibility was made for cefoxitin and penicillin. Nitrocefin disks were used to detect β-lactamase production.
    [Show full text]
  • FTA-ABS Double Stain (Syphilis) IFA Kit
    DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 [email protected] [email protected] www.rapidtest.com See external label 2°C-8°C Σ=10 x 10 tests Cat # 351010-DS FTA-ABS Double Stain (Syphilis) IFA Kit Cat # 351010-DS INTEDED USE The Diagnostic Automation, Inc. FTA-ABS Double Stain test system is designed to confirm positive non-treponemal reagin tests for syphilis and is for in vitro diagnostic use. This product is not FDA cleared (approved) for use in testing (i.e., screening) blood or plasma donors. SIGNIFICANCE AND BACKGROUND Serological procedures for syphilis are currently divided into two general groups of tests: 1. The non-treponemal antigen reagent screen tests, of which the Venereal Disease Research (VDRL) and Rapid Plasma Reagin Card (RPR) procedures are the most frequently employed. 2. The treponemal antigen tests, of which the Fluorescent Treponemal Antibody-Absorption (FTA- ABS), and more recently, the Fluorescent Treponemal Antibody-Absorption Double Stain (FTA- ABS-DS) test are the most commonly employed confirmatory test procedures (1-9). Although the nontreponemal tests such as the VDRL procedure provide a relatively simple and reliable means to screen syphilis patients, they also produce a significant number of biologically false positive DAI Code # 2 1 (BFP) reactions. These reactions are defined as patients whose sera give a positive VDRL reaction (usually weakly reactive or titer less than 1:8), a negative FTA-ABS and no history or physically findings to suggest syphilis (10-11). Consequently, a VDRL positive screen should be confirmed with a more specific test for syphilis such as the FTA-ABS procedure.
    [Show full text]
  • Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus
    Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus human immunodeficiency including Laboratory transmitted infections, diagnosis of sexually Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard, Catherine Ison, David Lewis, Francis Ndowa, Rosanna Peeling For more information, please contact: Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland ISBN 978 92 4 150584 0 Fax: +41 22 791 4171 E-mail: [email protected] www.who.int/reproductivehealth 7892419 505840 WHO_STI-HIV_lab_manual_cover_final_spread_revised.indd 1 02/07/2013 14:45 Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard Catherine Ison David Lewis Francis Ndowa Rosanna Peeling WHO Library Cataloguing-in-Publication Data Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus / edited by Magnus Unemo … [et al]. 1.Sexually transmitted diseases – diagnosis. 2.HIV infections – diagnosis. 3.Diagnostic techniques and procedures. 4.Laboratories. I.Unemo, Magnus. II.Ballard, Ronald. III.Ison, Catherine. IV.Lewis, David. V.Ndowa, Francis. VI.Peeling, Rosanna. VII.World Health Organization. ISBN 978 92 4 150584 0 (NLM classification: WC 503.1) © World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).
    [Show full text]